TABLE 5.
Comparison of the variables between survivors and non-survivors.
| Variables | Survivors (n = 105) | Non-survivors (n = 5) | p-value |
| Age (years) | 30.87 ± 4.77 | 30.2 ± 4.6 | 0.26 |
| History of hypertension | 12 (11.4%) | 1 (20%) | 0.562 |
| Multipara | 45 (42.9%) | 2 (40%) | 0.9 |
| Cesarean delivery | 97 (92.4%) | 4 (80%) | 0.324 |
| Eclampsia | 23 (21.9%) | 1 (20%) | 0.92 |
| Bleeding (>400 ml) | 25 (23.8%) | 1 (20%) | 0.845 |
| Infection | 11 (10.5%) | 4 (80%) | <0.001 |
| Perinatal death | 30 (28.6%) | 5 (100%) | <0.001 |
| SBP ≥ 160 mmHg | 60 (57.1%) | 5 (100%) | <0.001 |
| DBP ≥ 110 mmHg | 56 (53.3%) | 5 (100%) | <0.001 |
| Onset time of HELLP (weeks) | 31.37 ± 3.36 | 33.4 ± 3.05 | 0.189 |
| Lowest platelet count (×109 cell/L) | 47.07 ± 15.39 | 41.45 ± 19.95 | 0.433 |
| Lowest hemoglobin (g/L) | 84.52 ± 13.53 | 69.18 ± 5.28 | 0.013 |
| LDH (U/L) | 910.81 ± 295.81 | 1238.27 ± 563.62 | 0.023 |
| AST (U/L) | 184.74 ± 92.81 | 146.01 ± 41.33 | 0.357 |
| ALT (U/L) | 193.34 ± 64.96 | 164.67 ± 71.98 | 0.339 |
| Bilirubin (μmol/L) | 35.87 ± 27.56 | 76.11 ± 32.38 | 0.002 |
| Serum creatinine (μmol/L) | 142.61 ± 105.33 | 393.31 ± 183.04 | <0.001 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; LDH, lactate dehydrogenase; and AST, aspartate transaminase.